{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T04:37:33Z","timestamp":1785299853410,"version":"3.55.0"},"reference-count":13,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,26]],"date-time":"2021-09-26T00:00:00Z","timestamp":1632614400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.ijid.2021.09.061","type":"journal-article","created":{"date-parts":[[2021,9,29]],"date-time":"2021-09-29T10:11:25Z","timestamp":1632910285000},"page":"327-329","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Human herpesvirus 6 myelitis after chimeric antigen receptor T-cell therapy"],"prefix":"10.1016","volume":"112","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1678-5848","authenticated-orcid":false,"given":"Guy","family":"Handley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fareed","family":"Khawaja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divya S.","family":"Kondapi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hun J.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory P.","family":"Kaufman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sattva S.","family":"Neelapu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis E.","family":"Fayad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudhakar","family":"Tummala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Strati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor E.","family":"Mulanovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2021.09.061_bib0001","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1056\/NEJM199408183310703","article-title":"Human herpesvirus-6 infection in children","volume":"331","author":"Hall","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2021.09.061_bib0002","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1182\/blood-2017-07-793760","article-title":"Infectious complications of CD19-targeted chimeric antigen receptor-modified T-cell immunotherapy","volume":"131","author":"Hill","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.ijid.2021.09.061_bib0003","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.bbmt.2018.12.758","article-title":"ASTCT consensus grading for cytokine release syndrome and neurologic toxicity associated with immune effector cells","volume":"25","author":"Lee","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.ijid.2021.09.061_bib0004","doi-asserted-by":"crossref","first-page":"e12682","DOI":"10.1111\/tid.12682","article-title":"Risk factors of human herpesvirus 6 encephalitis\/myelitis after allogeneic hematopoietic stem cell transplantation","volume":"19","author":"Miyashita","year":"2017","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.ijid.2021.09.061_bib0005","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.3324\/haematol.2020.259952","article-title":"Acute leukoencephalomyelopathy and quadriparesis after CAR T-cell therapy","volume":"106","author":"Nair","year":"2021","journal-title":"Haematologica"},{"key":"10.1016\/j.ijid.2021.09.061_bib0006","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1093\/cid\/ciy152","article-title":"Cytokine release syndrome grade as a predictive marker for infections in patients with relapsed or refractory B-cell acute lymphoblastic leukemia treated with chimeric antigen receptor T cells","volume":"67","author":"Park","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2021.09.061_bib0007","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1126\/science.2876520","article-title":"Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders","volume":"234","author":"Salahuddin","year":"1986","journal-title":"Science"},{"key":"10.1016\/j.ijid.2021.09.061_bib0008","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1212\/01.wnl.0000265591.10200.d7","article-title":"Post-transplant acute limbic encephalitis: clinical features and relationship to HHV6","volume":"69","author":"Seeley","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.ijid.2021.09.061_bib0009","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1440-1789.2009.01020.x","article-title":"Human herpes virus 6 encephalomyelitis after bone marrow transplantation: report of an autopsy case","volume":"30","author":"Shintaku","year":"2010","journal-title":"Neuropathology"},{"key":"10.1016\/j.ijid.2021.09.061_bib0010","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/s41409-019-0755-2","article-title":"Clinical characteristics of human herpesvirus-6 myelitis after allogeneic hematopoietic stem cell transplantation and its favorable outcome by early intervention","volume":"55","author":"Shiroshita","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.ijid.2021.09.061_bib0011","doi-asserted-by":"crossref","first-page":"3943","DOI":"10.1182\/bloodadvances.2020002228","article-title":"Clinical and radiologic correlates of neurotoxicity after axicabtagene ciloleucel in large B-cell lymphoma","volume":"4","author":"Strati","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.ijid.2021.09.061_bib0012","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.3324\/haematol.2020.254045","article-title":"Hematopoietic recovery and immune reconstitution after axicabtagene ciloleucel in patients with large B-cell lymphoma","volume":"106","author":"Strati","year":"2021","journal-title":"Haematologica"},{"key":"10.1016\/j.ijid.2021.09.061_bib0013","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1086\/322642","article-title":"Human herpes virus 6 reactivation and encephalitis in allogeneic bone marrow transplant recipients","volume":"33","author":"Zerr","year":"2001","journal-title":"Clin Infect Dis"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971221007694?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971221007694?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T08:04:47Z","timestamp":1761120287000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971221007694"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":13,"alternative-id":["S1201971221007694"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2021.09.061","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human herpesvirus 6 myelitis after chimeric antigen receptor T-cell therapy","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2021.09.061","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}]}}